<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: To investigate the correlation of <z:mp ids='MP_0001548'>hyperlipemia</z:mp> (<z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>) and <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>/reperfusion (I/R) injury on liver damage and its mechanism </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Rats were divided into 4 groups: control, <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>, I/R and <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>+I/R </plain></SENT>
<SENT sid="2" pm="."><plain>After the induction of <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e> via a high-fat diet for 18 wk, middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> was followed by 24 h of reperfusion to capture I/R </plain></SENT>
<SENT sid="3" pm="."><plain>Serum alanine transaminase (ALT) and <z:chebi fb="0" ids="29995">aspartate</z:chebi> aminotransferase (AST) were analyzed as part of liver function tests and liver damage was further assessed by histological examination </plain></SENT>
<SENT sid="4" pm="."><plain>Hepatocyte <z:mpath ids='MPATH_3'>apoptosis</z:mpath> was evaluated by terminal deoxynucleotidyl transferase <z:chebi fb="0" ids="17625">dUTP</z:chebi> nick-end labeling (TUNEL) assay </plain></SENT>
<SENT sid="5" pm="."><plain>The expression of genes related to <z:mpath ids='MPATH_3'>apoptosis</z:mpath> (caspase-3, bcl-2) was assayed by immunohistochemistry and Western blotting </plain></SENT>
<SENT sid="6" pm="."><plain>Serum <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-α (TNF-α), interleukin-1 (IL-1) and liver <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> <z:chebi fb="1" ids="18421">superoxide</z:chebi> dismutase (SOD), <z:chebi fb="0" ids="16856">glutathione</z:chebi> peroxidase (GSH-Px), malondialdehyde (<z:chebi fb="14" ids="32506">MDA</z:chebi>) and Ca(2+) levels were measured to determine inflammatory and oxidative/antioxidative status respectively </plain></SENT>
<SENT sid="7" pm="."><plain>Microsomal hydroxylase activity of the <z:chebi fb="0" ids="38559">cytochrome P450</z:chebi> 2E1 (CYP2E1)-containing enzyme was measured with <z:chebi fb="6" ids="17296">aniline</z:chebi> as the substrate, and CYP2E1 expression in the liver tissue and microsome was determined by immunohistochemistry and Western blotting respectively </plain></SENT>
<SENT sid="8" pm="."><plain>RESULTS: <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e> alone induced by high-fat diet for 18 wk resulted in liver damage, indicated by histopathological analysis, and a considerable increase in serum ALT (25.13 ± 16.90 vs 9.56 ± 1.99, P &lt; 0.01) and AST levels (18.01 ± 10.00 vs 11.33 ± 4.17, P &lt; 0.05) compared with control </plain></SENT>
<SENT sid="9" pm="."><plain>Moreover, <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e> alone induced hepatocyte <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, which was determined by increased TUNEL-positive cells (4.47 ± 0.45 vs 1.5 ± 0.22, P &lt; 0.01), higher caspase-3 and lower bcl-2 expression </plain></SENT>
<SENT sid="10" pm="."><plain>Interestingly, compared with those in control, <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e> or I/R groups, massive increases of serum ALT (93.62 ± 24.00 vs 9.56 ± 1.99, 25.13 ± 16.90 or 12.93 ± 6.14, P &lt; 0.01) and AST (82.32 ± 26.92 vs 11.33 ± 4.17, 18.01 ± 10.00 or 14.00 ± 6.19, P &lt; 0.01) levels in <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>+I/R group were observed suggesting severe liver damage, which was confirmed by liver histology </plain></SENT>
<SENT sid="11" pm="."><plain>In addition, <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e> combined with I/R also caused significantly <z:mp ids='MP_0003887'>increased hepatocyte apoptosis</z:mp>, as evidenced by increased TUNEL-positive cells (6.20 ± 0.29 vs 1.5 ± 0.22, 4.47 ± 0.45 or 1.97 ± 0.47, P &lt; 0.01), elevated expression of caspase-3 and lower expression of bcl-2 </plain></SENT>
<SENT sid="12" pm="."><plain>Furthermore, when compared to <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e> or I/R alone, <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e> plus I/R enhanced serum TNF-α, IL-1, liver <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> <z:chebi fb="14" ids="32506">MDA</z:chebi> and Ca(2+) levels, suppressed SOD and GSH-Px in liver mitochondria, and markedly up-regulated the activity (11.76 ± 2.36 vs 4.77 ± 2.31 or 3.11 ± 1.35, P &lt; 0.01) and expression (3.24 ± 0.38 vs 1.98 ± 0.88 or 1.72 ± 0.58, P &lt; 0.01) of CYP2E1 in liver </plain></SENT>
<SENT sid="13" pm="."><plain>CONCLUSION: The coexistence of <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e> and <z:hpo ids='HP_0011009'>acute</z:hpo> cerebral I/R induces severe liver damage, suggesting that cerebral <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> would exaggerate the damage of liver caused by <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e> </plain></SENT>
<SENT sid="14" pm="."><plain>This effect is possibly due to enhanced CYP2E1 induction which further promotes oxidative damage, <z:mp ids='MP_0001845'>inflammation</z:mp> and hepatocyte <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
</text></document>